||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 520 active entries
Via delle Rose, 10 Loc. La Tognazza
Monteriggioni (SI), 53035
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
DIESSE Diagnostica Senese S.p.A. is an Italian manufacturer of innovative clinical systems. DIESSE was founded in 1982, thanks to a partnership between financial investors and top level researchers with long-standing experience in developing clinical diagnostic products and systems. Throughout its twenty-three year history, DIESSE has focused its efforts on developing a solid position in the market of hematology and infectious disease test systems. In the early years, the company capitalized on its reputation for manufacturing quality and excellent products for serology testing which allowed the company to expand its activities to other strategic markets.The initial development was greatly assisted by the invention and subsequent patenting of a revolutionary method for the determination of the erythrocyte sedimentation rate (ESR). Based on this technology, DIESSE developed the VESMATIC™ SYSTEM, which reduces the turn-around time of ESR testing by more than fifty percent eliminates the risk of direct exposure to blood samples. Additionally, VESMATIC Systems offer added safety and convenience through the use of non-glass tubes and small sample volume requirements.Considering product diversification vital for future growth, DIESSE decided to further expand and strengthen its position in other market segments, such as enzyme immunoassay, serology and microbiology. As a result of this strategy, DIESSE introduced SERAMAT, a fully automated system for serological testing which is able to use different analytical methods. SERAMAT was the first automatic instrument to perform complement fixation testing.In addition, DIESSE developed ROBOBACT, a unique system that allows for the automatic isolation of enteric and urinary pathogens, without opening sample containers.Furthermore, in 2005 DIESSE introduced two highly innovative systems: CHORUS and VES-CUBE. CHORUS is a multi-parametric processor for infectious diseases and autoimmunity using an innovative method of single- test and ready-to-use devices. VES-CUBE is a fully automated system for ESR testing in standard EDTA tubes; which are normally found with the most common cell counters, already loaded in racks.In early 2005, DIESSE opened DIESSE INC, its US subsidiary located in Florida, which is in charge of developing the business in the Americas. Diesse is moving its office from Hong Kong to China, opening a Representative Office in Shenzhen, China in March 2006. It is another step for the expansion of the Diesse's business into the territory of China to support the marketing networks that has been established in these past years.
Diesse has also a Regional Scientific Office in Riyadh (Saudi Arabia) to support the business activities in the Gulf countries.
Last update of this entry: June 18, 2011